Clinical trial
Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel
NCT05201781 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Lead sponsor
- Janssen Research & Development, LLC
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 9, 2022
- Completion date
- June 28, 2041
- Enrollment
- 295 (estimated)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.